ABSTRACT
BACKGROUND: Bevacizumab, a recombinant humanized monoclonal antibody that blocks angiogenesis by inhibiting vascular endothelial growth factor A, was described to be effective in the treatment of recurrent or platinum‑resistance ovarian cancer. The present retrospective study was performed to further evaluate the clinical efficacy and toxicity of bevacizumab in the treatment of Chinese recurrent ovarian cancer patients who had been previously treated by platinum‑based chemotherapy. MATERIALS AND METHODS: We reviewed the hospital database and finally included 26 recurrent ovarian cancer patients who were treated with bevacizumab combined with gemcibabine or paclitaxel or single agent. All included patients received >3 cycle of bevacizumab treatment. The tumor response, overall survival, and toxicities were documented. RESULTS: Under the treatment of bevacizumab combined with gemcibabine or paclitaxel, 2 complete response (7.7%), 8 partial response (30.8%), 7 stable disease (26.9%) and 9 progression disease (34.6%) was documented with the objective response rate of 38.5% and disease control rate of 65.4%. The median overall survival from the first application of bevacizumab was 15.3 months [Figure 1] for all of the 26 patients. The median overall survival time was 16.2 and 14.0 months for bevacizumab + gemcitabine and bevacizumab + paclitaxel treatment schedule respectively. The overall survival was not different between bevacizumab + gemcitabine and bevacizumab + paclitaxel treatment regimen hazard ratio = 0.80 (95% confidence interval: 0.32–2, P = 0.64). The hypertension and proteinuria were the major bevacizumab related toxicities. CONCLUSIONS: Bevacizumab combined with gemcibabine or paclitaxel was a promising treatment schedule for platinum‑resistance recurrent ovarian cancer.
ABSTRACT
OBJECTIVES: The aim of this study was to observe the influence of orthodontic treatment on the hyoid position of patients with different vertical skeletal craniofacial patterns of mandibular deviations. METHODS: A total of 60 patients with mandibular deviations, including 30 males and 30 females with a mean age of 15.4 years, were recruited. They were equally divided into average angle, high angle, and low angle groups, with a 1:1 gender ratio. Their hyoid position was measured before and after orthodontic treatment. The data were analysed using paired ttests and analysis of variance (ANOVA). RESULTS: After treatment, the hyoid body in the high angle group presented significant forward and upward movements (p = 0.012 and p = 0.005). The hyoid body in the low angle group exhibited significant forward movement (p = 0.048) and a significant increase in the hyoid inclination (p = 0.00). In the average angle group, the hyoid body significantly moved downward (p = 0.031) and the thyrohyoid moved upward (p = 0.046). The ANOVA showed that orthodontic treatment significantly influenced the vertical position and inclination degree of the hyoid (F = 6.37, p = 0.003; F = 6.204, p = 0.004; and F = 3.393, p = 0.025). The average angle group displayed significant differences in these indices compared with the high angle and low angle groups. Orthodontic treatment significantly influenced the mandibular plane angle in the high angle group (p = 0.012). CONCLUSION: Orthodontic treatment influences the hyoid position of patients with different vertical skeletal craniofacial patterns of mandibular deviations by varying degrees.
OBJETIVOS: El objetivo de este estudio fue observar la influencia del tratamiento ortodóntico en la posición hioidea de pacientes con diferentes patrones craneofaciales esqueléticos verticales de desviaciones mandibulares. MÉTODOS: Se reclutaron un total de 60 pacientes con desviaciones mandibulares, incluyendo 30 hombres y 30 mujeres con una edad media de 15.4 años. Los pacientes fueron divididos a partes iguales en grupos de ángulo promedio, ángulo alto, y ángulo bajo, con una proporción de género de 1:1. Su posición hioidea fue medida antes y después del tratamiento ortodóntico. Los datos se analizaron mediante pruebas t pareadas y análisis de varianza (ANOVA). RESULTADOS: Luego del tratamiento, el cuerpo del hioides en el grupo de ángulo alto presentó movimientos significativos hacia adelante y hacia arriba (p= 0.012 y p= 0.005). El cuerpo del hioides en el grupo de bajo ángulo exhibió avance significativo (p = 0.048) y un aumento significativo en la inclinación del hioides (p = 0.00). En el grupo de ángulo promedio, el cuerpo del hioides se movió significativamente hacia abajo (p = 0.031) y el tirohioideo se movió hacia arriba (p = 0.046). El Orthodontic Treatment of Patients with Mandibular Deviation análisis de ANOVA mostró que el tratamiento ortodóntico influye significativamente sobre el grado de inclinación y posición vertical del hioides (F = 6.37, p = 0. 003; F = 6.204, p = 0.004 y F = 3.393, p = 0. 025). El grupo de ángulo promedio mostró diferencias significativas en estos índices en comparación con los grupos de ángulo bajo y ángulo alto. El tratamiento ortodóntico influyó significativamente en el ángulo del plano de la mandíbula en el grupo de alto ángulo (p = 0.012). CONCLUSIÓN: El tratamiento ortodóntico influye en la posición hioidea de pacientes con diferentes patrones craneofaciales esqueléticos verticales de desviaciones mandibulares de diversos grados.